PLoS ONE · 2014 · 191 citations · 28 references
MedicineInternal MedicineNephrologyDiabetologyRenal PathologyRenal PathophysiologyChronic Kidney DiseaseDiabetes MellitusDiabetic NephropathyRenal DiseaseRenal Function TestsRenal ImpairmentChronic Kidney Disease EpidemiologyDiabetes DurationDiabetes-related ComplicationsEnd-stage Kidney Disease DosingPrevalence Estimation
AIMS: The prevalence of diabetic nephropathy and its risk factors have not been studied in a society known to have diabetes epidemic like Saudi Arabia. Using a large data base registry will provide a better understanding and accurate assessment of this chronic complication and its related risk factors. METHODOLOGY: A total of 54,670 patients with type 2 diabetes aged ≥ 25 years were selected from the Saudi National Diabetes Registry (SNDR) and analyzed for the presence of diabetic nephropathy. The American Diabetes Association (ADA) criterion was used to identify cases with microalbuminuria, macroalbuminuria and end stage renal disease (ESRD) for prevalence estimation and risk factor assessment. RESULTS: The overall prevalence of diabetic nephropathy was 10.8%, divided into 1.2% microalbuminuria, 8.1%macroalbuninuria and 1.5% ESRD. Age and diabetes duration as important risk factors have a strong impact on the prevalence of diabetic nephropathy, ranging from 3.7% in patients aged 25-44 years and a duration of >5 years, to 21.8% in patients ≥ 65 years with a diabetes duration of ≥ 15 years. Diabetes duration, retinopathy, neuropathy, hypertension, age >45 years, hyperlipidemia, male gender, smoking, and chronologically, poor glycemic control has a significantly high risk for diabetic nephropathy. CONCLUSION: The prevalence of diabetic nephropathy is underestimated as a result of a shortage of screening programs. Risk factors related to diabetic nephropathy in this society are similar to other societies. There is thus an urgent need for screening and prevention programs for diabetic nephropathy among the Saudi population.
28
Body Mass Index and Risk for End-Stage Renal Disease
Chi‐yuan Hsu, Charles E. McCulloch, Carlos Iribarren et al. · Annals of Internal Medicine · 2006 · 1.4K citations
Risk Factors for Renal Dysfunction in Type 2 Diabetes
Ravi Retnakaran, C A Cull, Kerensa Thorne et al. · Diabetes · 2006 · 934 citations · Full text
Medicine, Nephrology, Diabetology +14
Obesity and Risk for Chronic Renal Failure
Elisabeth Ejerblad, C. Michael Fored, Per Lindblad et al. · Journal of the American Society of Nephrology · 2006 · 682 citations
Carlos Lorenzo, Ken Williams, Kelly J. Hunt et al. · Diabetes Care · 2006 · 663 citations · Full text